Sup. Figure 2: KM12SM-ER cells were resistant to treatment with 15mg/kg and 30mg/kg entrectinib in the brain metastasis-mimicking model. from Foretinib Overcomes Entrectinib Resistance Associated with the &lt;i&gt;NTRK1&lt;/i&gt; G667C Mutation in &lt;i&gt;NTRK1&lt;/i&gt; Fusion–Positive Tumor Cells in a Brain Metastasis Model